The effect of age on survival.

Figure 3A shows the influence of age on matched transplants for CML chronic phase after receiving a preparative regimen of total body irradiation/ (TBI/CY).

Figure 3B shows the survival after targeted busulfan/CY (BU/CY). There is no significant difference in the survival of these age cohorts up to age 65.